Insights into a Phase III trial of icotinib for resected EGFR-mutated stage II-IIIA NSCLC

3.9K views

VJOncology

5 months ago

Insights into a Phase III trial of icotinib for resected EGFR-mutated stage II-IIIA NSCLC

Insights into a Phase III trial of icotinib for resected EGFR-mutated stage II-IIIA NSCLC